Evidence map›Paper›PMID 20567595›Full record

ArticlePloS one2010

MSH2/MSH6 complex promotes error-free repair of AID-induced dU:G mispairs as well as error-prone hypermutation of A:T sites.

Sergio Roa, Ziqiang Li, Jonathan U Peled, Chunfang Zhao, Winfried Edelmann, Matthew D Scharff

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Novel Implications in Molecular Diagnosis of Lynch Syndrome.Gastroenterology research and practice · 2017
    Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Mammalian Exo1 encodes both structural and catalytic functions that play distinct roles in essential biological processes.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sergio RoaDepartment of Cell Biology, Albert Einstein College of Medicine, New York, New York, USA.
Ziqiang Li
Jonathan U Peled
Chunfang Zhao
Winfried Edelmann
Matthew D Scharff
Albert Einstein College of Medicine · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007288 · NIGMS · YESHIVA UNIVERSITY · PI AKABAS, MYLES H. · 1985 to 2022
$35.6M
DNA MISMATCH REPAIR AND CANCER IN MURINE MODELSR01CA076329 · NCI · YESHIVA UNIVERSITY · PI EDELMANN, WINFRIED · 1998 to 2017
$6.9M
SOMATIC MUTATION OF IG VARIABLE REGIONSR01CA072649 · NCI · YESHIVA UNIVERSITY · PI SCHARFF, MATTHEW D · 1997 to 2014
$5.0M
The Role of Late MMR Proteins in DNA Repair and CancerR01CA093484 · NCI · YESHIVA UNIVERSITY · PI EDELMANN, WINFRIED · 2002 to 2011
$3.7M
Mismatch repair in V region mutation and isotype switchingR01CA102705 · NCI · YESHIVA UNIVERSITY · PI SCHARFF, MATTHEW D · 2003 to 2013
$3.2M
NCI NIH HHS R01 CA072649NCI NIH HHS R01 CA076329NCI NIH HHS R01 CA093484NCI NIH HHS R01 CA102705NCI NIH HHS R01CA102705NCI NIH HHS R01CA72649NCI NIH HHS R01CA7632NCI NIH HHS R01CA93484NIGMS NIH HHS T32 GM 007288NIGMS NIH HHS T32 GM007288
6 · The paper itself

Abstract

Mismatch repair of AID-generated dU:G mispairs is critical for class switch recombination (CSR) and somatic hypermutation (SHM) in B cells. The generation of a previously unavailable Msh2(-/-)Msh6(-/-) mouse has for the first time allowed us to examine the impact of the complete loss of MutSalpha on lymphomagenesis, CSR and SHM. The onset of T cell lymphomas and the survival of Msh2(-/-)Msh6(-/-) and Msh2(-/-)Msh6(-/-)Msh3(-/-) mice are indistinguishable from Msh2(-/-) mice, suggesting that MSH2 plays the critical role in protecting T cells from malignant transformation, presumably because it is essential for the formation of stable MutSalpha heterodimers that maintain genomic stability. The similar defects on switching in Msh2(-/-), Msh2(-/-)Msh6(-/-) and Msh2(-/-)Msh6(-/-)Msh3(-/-) mice confirm that MutSalpha but not MutSbeta plays an important role in CSR. Analysis of SHM in Msh2(-/-)Msh6(-/-) mice not only confirmed the error-prone role of MutSalpha in the generation of strand biased mutations at A:T bases, but also revealed an error-free role of MutSalpha when repairing some of the dU:G mispairs generated by AID on both DNA strands. We propose a model for the role of MutSalpha at the immunoglobulin locus where the local balance of error-free and error-prone repair has an impact in the spectrum of mutations introduced during Phase 2 of SHM.

Indexed as

Base Pair MismatchMutationAICDA (Activation-Induced Cytidine Deaminase)AnimalsCytidine DeaminaseDimerizationDNA-Binding ProteinsLymphomaMiceMice, Inbred C57BLMice, KnockoutMutS Homolog 2 ProteinRecombination, GeneticAICDA (Activation-Induced Cytidine Deaminase)Cytidine DeaminaseDNA-Binding ProteinsMsh2 protein, mouseMsh6 protein, mouseMutS Homolog 2 Protein

Identifiers

PMID20567595
PMCPMC2887398
OpenAlexW2057448179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.